Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Dodge & Cox Stock Fund | 22.47% | 59.88M | 3.1B |
| Dodge & Cox Balanced Fund | 2.57% | 6.84M | 354.7M |
| John Hancock Mutual Fds III-Disciplined Value Fd | 2.41% | 6.43M | 333.29M |
| Invesco Comstock Fd | 1.28% | 3.41M | 176.55M |
| Fidelity Equity Dividend Income Fund | 1.22% | 3.25M | 168.45M |
| Fidelity Series Value Discovery Fund | 1.03% | 2.75M | 142.42M |
| Fidelity Strategic Advisers Fidelity U.S. Total Stock Fund | 0.76% | 2.03M | 105.23M |
| Fidelity Select Portfolios - Pharmaceuticals | 0.50% | 1.33M | 69.05M |
| First Tr Exchange Traded Fd-First Tr Value Line Dividend Index | 0.50% | 1.33M | 68.95M |
| Vanguard/Windsor II | 0.50% | 1.32M | 68.44M |
GLP-1 Receptor Agonist (Trulicity, Wegovy, Ozempic, Mounjaro) Market Trends Analysis Report 2026
03/05 11:58 am
GlobeNewswire Inc.
Read moreCytokines Market Global Forecast 2026-2032: Precise Treatments, Strategic Partnerships, and Supply Chain Resilience Fueling the $95+ Billion Market
03/05 05:44 am
GlobeNewswire Inc.
Read moreTeva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance duvakitug
03/03 06:00 pm
GlobeNewswire Inc.
Read moreAntibiotics Market - 4.07% CAGR Forecast for 2026-2031 as Antimicrobial Innovation Strengthens Demand, Says Mordor Intelligence
03/02 05:59 am
GlobeNewswire Inc.
Read moreCommuniqué de presse: L’acoziborole Winthrop, développé par DNDi et Sanofi, reçoit l’avis positif du CHMP comme traitement à dose unique à trois comprimés pour la forme la plus fréquente de la maladie du sommeil
02/27 06:55 am
GlobeNewswire Inc.
Read morePress Release: Acoziborole Winthrop, developed by DNDi and Sanofi, receives CHMP positive opinion as three-tablet, single-dose treatment for most common form of sleeping sickness
02/27 06:55 am
GlobeNewswire Inc.
Read moreCytokinetics Reports Fourth Quarter 2025 Financial Results and Provides Business Update
02/24 05:00 pm
GlobeNewswire Inc.
Read moreRegeneron, Sanofi Blockbuster Dupixent Scores FDA Nod For Rare Sinus Condition
02/24 02:47 pm
Benzinga
Read moreFDA Grants Breakthrough Status To Johnson & Johnson's Cancer Drug For Advanced Head and Neck Cancer
02/18 11:10 am
Benzinga
Read moreTurner Syndrome Market Size to Reach USD 3.67 Billion by 2033, Fueled by Early Diagnosis Advances and Rising Awareness of Rare Chromosomal Disorders – SNS Insider
02/18 06:55 am
GlobeNewswire Inc.
Read morePress release: Filing of the 2025 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
02/17 02:00 pm
GlobeNewswire Inc.
Read moreCommuniqué de presse : Dépôt du Document d’Enregistrement Universel 2025, contenant le Rapport Financier Annuel, et du « Form 20-F » américain
02/17 02:00 pm
GlobeNewswire Inc.
Read moreTeva Pharmaceutical's New Study Shows Lasting Relief For Inflammatory Bowel Disease Patients
02/17 08:04 am
Benzinga
Read moreTeva and Sanofi’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease
02/17 07:00 am
GlobeNewswire Inc.
Read morePress Release: Sanofi and Teva’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease
02/17 07:00 am
GlobeNewswire Inc.
Read moreCommuniqué de presse : Les données de phase IIb de l’étude d’entretien sur le duvakitug de Sanofi et Teva ont démontré une efficacité durable cliniquement significative dans la colite ulcéreuse et la maladie de Crohn
02/17 07:00 am
GlobeNewswire Inc.
Read moreUterine Fibroid Market Size to Reach USD 9.43 Billion by 2033 with 7.63% CAGR – SNS Insider
02/16 09:00 am
GlobeNewswire Inc.
Read moreSanofi Stock Near 52-Week Low As Leadership Shakeup Rattles Investors
02/13 09:23 am
Benzinga
Read moreNIH Stops Johnson & Johnson's Blood Thinner Drug Arm In Stroke Trial After Safety Review (UPDATED)
02/12 03:55 pm
Benzinga
Read moreSanofi Shocker: CEO Paul Hudson Out As Board Demands 'Increased Rigor'
02/12 07:28 am
Benzinga
Read moreAnti-Obesity Drugs Market to Reach US$195.99 Billion by 2036 as GLP-1 Therapies Drive a Structural Shift in Weight Management
02/06 06:00 am
GlobeNewswire Inc.
Read moreObesity Treatment Market Size to Reach USD 75.69 Billion by 2033 as the Treatment Offers a Comprehensive Evaluation of Therapeutic Developments Globally
02/05 05:00 am
GlobeNewswire Inc.
Read moreHuman Vaccines Market Size to Reach USD 62.45 Billion by 2033, Driven by Expanding Immunization Programs – SNS Insider
02/05 04:57 am
GlobeNewswire Inc.
Read moreSanofi Plans Regulatory Submission For Investigational Drug For Rare Disease Despite Mixed Data From Pivotal Trials
02/02 09:30 am
Benzinga
Read moreRegeneron Posts Lower Eylea Sales Amid Rising Competition, Plans $2 Billion New Factory
01/30 11:56 am
Benzinga
Read moreSanofi Warns Dupixent Is Too Big To Replace As Patent Clock Ticks
01/29 08:08 am
Benzinga
Read moreAtopic Dermatitis Market to Reach USD 12.97 Billion by 2034, Growing at 7.75% CAGR
01/27 11:00 am
GlobeNewswire Inc.
Read moreCogent's New Stomach Cancer Treatment Cuts Progression Risk In Half, Gets Breakthrough Therapy Tag
01/26 11:06 am
Benzinga
Read moreSanofi Plans Regulatory Filings For Dupixent's Successor Despite Mixed Data From Pivotal Studies
01/23 08:02 am
Benzinga
Read moreFDA Shows Caution, Delays Trump-Backed Fast-Track Drugs Over Risks (UPDATED)
01/16 09:32 am
Benzinga
Read moreKymera Therapeutics Outlines Key 2026 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs
01/13 08:00 am
GlobeNewswire Inc.
Read moreRegeneron Just Moved From Underperform To Buy - Here's Why
01/07 05:18 pm
Benzinga
Read moreFDA Flags Liver Injury Risk In Sanofi's Rejected Multiple Sclerosis Drug
01/06 09:54 am
Benzinga
Read moreCytokinetics to Present at the 44th Annual J.P. Morgan Healthcare Conference
01/05 05:00 pm
GlobeNewswire Inc.
Read moreDrugmakers Plan Fresh Price Hikes On 350 Medicines In 2026
12/31 09:59 am
Benzinga
Read moreCeliac Disease Market Report 2025-2035: Drivers, Challenges, Opportunities, Industry Trends and Case Studies
12/30 11:51 am
GlobeNewswire Inc.
Read moreStock Market Today: Records, Metals Mania and Mixed Tech Tape
12/25 02:07 am
Investing.com
Read moreCytokinetics Announces FDA Approval of MYQORZO™ (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms
12/19 05:00 pm
GlobeNewswire Inc.
Read moreAntibody Optimization Service Market Set to Reach USD 6.07 Billion by 2034, Growing at an 8.45% CAGR Amid Advances in Gene-Editing Technologies
12/17 11:00 am
GlobeNewswire Inc.
Read moreCommuniqué de presse : Mise en ligne du document «Q4 2025 Aide mémoire »
12/17 02:30 am
GlobeNewswire Inc.
Read morePress release: Availability of the Q4 2025 Aide memoire
12/17 02:30 am
GlobeNewswire Inc.
Read moreSanofi Expands Dren Bio Partnership With Potential $1.7 Billion Autoimmune Disease Collaboration
12/15 02:10 pm
Benzinga
Read more